ARTICLE | Company News
Gilead, Amygdala deal
February 17, 2017 7:49 PM UTC
Amygdala acquired GS-6637 from Gilead. Gilead received an equity stake and is eligible for undisclosed milestones and royalties. Amygdala expects to begin two or three Phase II trials this year of GS-...
BCIQ Target Profiles